ImmuneSensor Therapeutics Inc.
ImmuneSensor Therapeutics Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1b Safety Study of IMSB301 in Type 1 Interferonopathies | Type 1 Interferonopathies | Recruiting | Phase 1 | 2026-01-23 | NCT07364513 | |
| A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial | Solid Tumor, Adult | Active, not recruiting | Phase 1 | 2024-11-18 | NCT06026254 |